People living with HIV are demanding constant supply of quality and standard antiretrovirals (ARVs).
This follows an outcry that there has been shortage of some types of ARVs, forcing individuals to take expired medicines.
There have also been reports of shortages of infant prophylaxis drugs including Nevirapine and Zidovudine, used to prevent mother to child transmission of HIV.
However, the National Aids and STIs Control Programme (NASCOP) and Kenya Medical Supplies Authority (Kemsa) have maintained that there is no national shortage of ARVs.
Head of NASCOP, Andrew Mulwa, maintained there is no shortage of Navirapine.
